Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies ...

Alcon and RxSight partner to develop light-adjustable presbyopia-correcting IOLs, including $60M upfront and milestone payments.

Alcon Silver Corp. ("Alcon") and Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold") announce that, in connection with the ...

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...

MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of Directors, effective today, expanding the Board from nine ...

GENEVA--(BUSINESS WIRE)--Regulatory News: Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed binding ...

Alcon’s ALC new platforms and lenses are gaining adoption. Dry eye momentum is likely to support growth in the upcoming ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Add Yahoo as a preferred source to see more of our stories on Google. Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a major expansion of its ...

Alcon innovations featured in more than 75 abstracts across cataract, refractive, visualization and ocular health1 Clinical data presentations and sponsored symposia to highlight the efficacy of Alcon ...

Alcon Inc. Annual stock financials by MarketWatch. View the latest ALC financial statements, income statements and financial ratios.